Pharmaceutical Filtration Market Forecasts to 2028 - Global Analysis By Product, Technique, Type, Application and By Geography

According to Stratistics MRC, the Global Pharmaceutical Filtration Market is accounted for $22.3 billion in 2022 and is expected to reach $45.1 billion by 2028 growing at a CAGR of 12.4% during the forecast period. Pharmaceutical filtration is a separation procedure in which processed materials are passed through a filtration membrane in order to extract undesirable particles from them. This filtration technique aids in removing suspended particles from a medium or solution. Additionally, pollutants like particle matter and bacteria are eliminated from solids, air, liquids, and gases using filters. The processing of final products, water purification, raw material filtration, cell separation, and air purification are a few other fields where pharmaceutical filtration techniques are commonly used.

According to Evaluate Pharma, worldwide pharmaceutical R&D spending was valued at USD 144 billion in 2014, and this figure is estimated to reach USD 285 billion by 2028.

Market Dynamics:

Driver:

Cleanliness requirements in pharmaceutical manufacturing facilities

To ensure the integrity and quality of the ultimate product, pharmaceutical businesses must maintain high cleanliness standards. The removal of pollutants and impurities from liquids and gases during production depends on the filtering systems. The rising demand for high-quality pharmaceutical products, as well as the need to meet regulatory requirements, is expected to drive market growth.

Restraint:

Requirement of high capital investments

The production of filtering equipment or systems requires a significant upfront financial expenditure. The cost of labour and other components such as technical expertise go into total manufacturing expenses. Large tangential flow filtration systems are expensive, but it costs more to put up a whole manufacturing complex with both upstream and downstream operations. The market's capital-intensive nature could impede market expansion.

Opportunity:

The rise in research and development activities

The increase in the number of research and development activities for developing generic pharmaceuticals and researching various healthcare therapies such as monoclonal antibodies, therapeutic proteins, and vaccines represents a growth opportunity for the market. The government increased spending to assist research and development activities is also projected to drive market growth.

Threat:

Increased regulations for the pharmaceutical industry

Pharmaceutical and biopharmaceutical manufacturing is closely regulated. The sanitation and quality of medications at each stage of the manufacturing process are governed by tight rules in a number of nations. As a result, producing medicines and biopharmaceuticals with conventional machinery is very expensive and difficult. The development of the pharmaceutical filtration market is hampered by the stringent regulations in the pharmaceutical sector.

COVID-19 Impact:

The usage of more sophisticated types of pharmaceutical filtration devices is a result of COVID-19's greater emphasis on safety standards and quality within the pharmaceutical business. Because single-use filtering technologies can prevent cross-contamination, the pandemic also saw an increase in their use in the pharmaceutical industry, which helped the market for pharmaceutical filtration. During the pandemic lockdown, the majority of pharmaceutical filter manufacturers in the world stopped producing their products.

The membrane filters segment is expected to be the largest during the forecast period

The membrane filters segment is estimated to have a lucrative growth, due to the capability of membrane filters to have a precise and uniform pore size distribution ensuring a consistent filtration quality. Membrane filters can also be created from a variety of materials, making them adaptable for use in pharmaceutical applications. Membrane filters also follow the manufacturing guidelines for pharmaceutical businesses.

The microfiltration segment is expected to have the highest CAGR during the forecast period

The microfiltration segment is anticipated to witness the fastest CAGR growth during the forecast period, due to its versatility and overall ability to remove a wide range of impurities from biopharmaceutical products. The method also filters out particles and contaminants without adversely affecting the medium's stability or biological activity. Additionally, producers of microfiltration systems are taking strategic actions that will support the market.

Region with Largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to surge in demand for pharmaceutical filtration products and rise in investments in the pharmaceutical and biopharmaceutical industry. In addition, the development of the R&D sector, the rise in healthcare reforms, improvements in healthcare infrastructure, rising disease prevalence, and technical developments in the healthcare industry all contribute to the market's expansion.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the adoption of innovative and latest technologies. The market is also expanding as a result of the rising demand for biopharmaceuticals and the development of the healthcare industry. The expansion and development of the pharmaceutical filtration industry in the region is also being aided by the region's robust distribution network.

Key players in the market:

Some of the key players profiled in the Pharmaceutical Filtration Market include Meissner Filtration Products, Inc., Parker Hannifin Corp., Merck KGaA, 3M Company, Eaton Corporation PLC, Thermo Fisher Scientific Inc., Danaher, Amazon Filters Ltd., Graver Technologies, Sartorius AG., GE Healthcare, Pall Corporation, Donaldson Company, Inc., Repligen Corporation and Membrane Solutions.

Key Developments:

In January 2023, Sartorius AG (Germany) and RoosterBio, Inc. (US) signed a collaboration deal to provide purification solutions and establish scalable downstream manufacturing processes for exosome-based therapies.

In June 2022, Donaldson Company Inc. (US) acquired Purilogics, LLC (US), an early-stage biotechnology company that manufactures membrane chromatography products. Through this acquisition, the company will have access to the purification tools for a wide range of biologics.

Products Covered:

• Prefilter & Depth Filter Media
• Membrane Filters
• Filter Holders
• Filtration Accessories
• Single-Use Systems
• Catriage & Capsules
• Other Products

Techniques Covered:

• Crossflow filtration
• Microfiltration
• Nanofiltration
• Ultrafiltration
• Other Techniques

Types Covered:

• Non-sterile
• Sterile
• Other Types

Applications Covered:

• Raw Material Filtration
• Final Product Processing
• Water Purification
• Air Purification
• Cell Separation
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options::

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances